Medicamen Biotech Limited
₹459.05
INR+7.10(+1.57%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹696.57 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹1059.99 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
85.87
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.86
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
44.04%
Operating Margin
Operating income as a percentage of revenue
3.89%
Return on Equity
Net income as a percentage of shareholders' equity
5.45%
Revenue (TTM)
Total revenue over trailing 12 months
₹180.41 Cr+2.6%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹21.27 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹6.38-67.7%
Balance Sheet
Total Cash
Total cash and short-term investments
₹14.79 Cr
Total Debt
Total short-term and long-term debt
₹30.82 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
15.37%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹355.45 - ₹689.55
Beta
Measure of stock's volatility compared to the market
1.46
Shares Outstanding
Total number of shares issued by the company
₹1.27 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.75%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
15.64%